SRx Health Solutions Statistics
Total Valuation
SRXH has a market cap or net worth of $6.40 million. The enterprise value is $43.86 million.
Important Dates
The last earnings date was Thursday, May 15, 2025, after market close.
Earnings Date | May 15, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
SRXH has 11.67 million shares outstanding.
Current Share Class | 11.67M |
Shares Outstanding | 11.67M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 5.69% |
Owned by Institutions (%) | 0.39% |
Float | 11.00M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 0.06 |
Forward PS | 0.89 |
PB Ratio | n/a |
P/TBV Ratio | n/a |
P/FCF Ratio | 4.06 |
P/OCF Ratio | 2.24 |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 0.37 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | 27.86 |
Financial Position
The company has a current ratio of 0.38
Current Ratio | 0.38 |
Quick Ratio | 0.28 |
Debt / Equity | n/a |
Debt / EBITDA | n/a |
Debt / FCF | 25.11 |
Interest Coverage | -4.26 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | -10.96% |
Return on Invested Capital (ROIC) | -20.97% |
Return on Capital Employed (ROCE) | 883.51% |
Revenue Per Employee | $254,089 |
Profits Per Employee | -$23,794 |
Employee Count | 470 |
Asset Turnover | 2.38 |
Inventory Turnover | 19.45 |
Taxes
In the past 12 months, SRXH has paid $197,376 in taxes.
Income Tax | 197,376 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -83.87% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -83.87% |
50-Day Moving Average | 1.12 |
200-Day Moving Average | 1.81 |
Relative Strength Index (RSI) | 36.52 |
Average Volume (20 Days) | 1,045,188 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SRXH had revenue of $119.42 million and -$11.18 million in losses. Loss per share was -$0.90.
Revenue | 119.42M |
Gross Profit | 23.71M |
Operating Income | -8.79M |
Pretax Income | n/a |
Net Income | -11.18M |
EBITDA | -7.08M |
EBIT | -8.79M |
Loss Per Share | -$0.90 |
Full Income Statement Balance Sheet
The company has $2.08 million in cash and $39.54 million in debt, giving a net cash position of -$37.47 million or -$3.21 per share.
Cash & Cash Equivalents | 2.08M |
Total Debt | 39.54M |
Net Cash | -37.47M |
Net Cash Per Share | -$3.21 |
Equity (Book Value) | -6.32M |
Book Value Per Share | -0.50 |
Working Capital | -40.53M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was $2.86 million and capital expenditures -$1.28 million, giving a free cash flow of $1.57 million.
Operating Cash Flow | 2.86M |
Capital Expenditures | -1.28M |
Free Cash Flow | 1.57M |
FCF Per Share | $0.13 |
Full Cash Flow Statement Margins
Gross margin is 19.85%, with operating and profit margins of -7.36% and -9.36%.
Gross Margin | 19.85% |
Operating Margin | -7.36% |
Pretax Margin | -9.20% |
Profit Margin | -9.36% |
EBITDA Margin | -5.93% |
EBIT Margin | -7.36% |
FCF Margin | 1.32% |
Dividends & Yields
SRXH does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | -174.82% |
FCF Yield | 24.61% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
SRXH has an Altman Z-Score of 0.26 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 0.26 |
Piotroski F-Score | 2 |